Cartiva, Inc., located in Alpharetta, Georgia, is a private, venture capital-backed company that was spun out from Carticept Medical, Inc. in December 2011. Cartiva is dedicated to improving the quality of life for patients with osteoarthritis or cartilage damage through the development of novel therapies. An estimated 27 million Americans suffer from osteoarthritis, a chronic degenerative joint disease characterized by the breakdown of the cartilage in the joint.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
07/15/13 | $4,300,000 | |||
05/11/15 | $8,500,000 | Series D |
Windham Venture Partners | undisclosed |